First Time Loading...

3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 6.1 HKD 4.63% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. [ Read More ]

The intrinsic value of one 3SBio Inc stock under the Base Case scenario is 8.83 HKD. Compared to the current market price of 6.1 HKD, 3SBio Inc is Undervalued by 31%.

Key Points:
Intrinsic Value
Base Case
8.83 HKD
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
3SBio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling 3SBio Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
3SBio Inc

Provide an overview of the primary business activities
of 3SBio Inc.

What unique competitive advantages
does 3SBio Inc hold over its rivals?

What risks and challenges
does 3SBio Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for 3SBio Inc.

Provide P/S
for 3SBio Inc.

Provide P/E
for 3SBio Inc.

Provide P/OCF
for 3SBio Inc.

Provide P/FCFE
for 3SBio Inc.

Provide P/B
for 3SBio Inc.

Provide EV/S
for 3SBio Inc.

Provide EV/GP
for 3SBio Inc.

Provide EV/EBITDA
for 3SBio Inc.

Provide EV/EBIT
for 3SBio Inc.

Provide EV/OCF
for 3SBio Inc.

Provide EV/FCFF
for 3SBio Inc.

Provide EV/IC
for 3SBio Inc.

Show me price targets
for 3SBio Inc made by professional analysts.

What are the Revenue projections
for 3SBio Inc?

How accurate were the past Revenue estimates
for 3SBio Inc?

What are the Net Income projections
for 3SBio Inc?

How accurate were the past Net Income estimates
for 3SBio Inc?

What are the EPS projections
for 3SBio Inc?

How accurate were the past EPS estimates
for 3SBio Inc?

What are the EBIT projections
for 3SBio Inc?

How accurate were the past EBIT estimates
for 3SBio Inc?

Compare the revenue forecasts
for 3SBio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of 3SBio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of 3SBio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of 3SBio Inc compared to its peers.

Compare the P/E ratios
of 3SBio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing 3SBio Inc with its peers.

Analyze the financial leverage
of 3SBio Inc compared to its main competitors.

Show all profitability ratios
for 3SBio Inc.

Provide ROE
for 3SBio Inc.

Provide ROA
for 3SBio Inc.

Provide ROIC
for 3SBio Inc.

Provide ROCE
for 3SBio Inc.

Provide Gross Margin
for 3SBio Inc.

Provide Operating Margin
for 3SBio Inc.

Provide Net Margin
for 3SBio Inc.

Provide FCF Margin
for 3SBio Inc.

Show all solvency ratios
for 3SBio Inc.

Provide D/E Ratio
for 3SBio Inc.

Provide D/A Ratio
for 3SBio Inc.

Provide Interest Coverage Ratio
for 3SBio Inc.

Provide Altman Z-Score Ratio
for 3SBio Inc.

Provide Quick Ratio
for 3SBio Inc.

Provide Current Ratio
for 3SBio Inc.

Provide Cash Ratio
for 3SBio Inc.

What is the historical Revenue growth
over the last 5 years for 3SBio Inc?

What is the historical Net Income growth
over the last 5 years for 3SBio Inc?

What is the current Free Cash Flow
of 3SBio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for 3SBio Inc.

Financials

Balance Sheet Decomposition
3SBio Inc

Current Assets 9.2B
Cash & Short-Term Investments 6B
Receivables 1.1B
Other Current Assets 2.1B
Non-Current Assets 14.4B
Long-Term Investments 3.1B
PP&E 5.1B
Intangibles 5.8B
Other Non-Current Assets 478m
Current Liabilities 3.7B
Accounts Payable 212.1m
Other Current Liabilities 3.5B
Non-Current Liabilities 5.9B
Long-Term Debt 2.7B
Other Non-Current Liabilities 3.1B
Efficiency

Earnings Waterfall
3SBio Inc

Revenue
7.8B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
6.6B CNY
Operating Expenses
-4.1B CNY
Operating Income
2.5B CNY
Other Expenses
-983.5m CNY
Net Income
1.5B CNY

Free Cash Flow Analysis
3SBio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

3SBio Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive Free Cash Flow
Positive Net Income
63/100
Profitability
Score

3SBio Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

3SBio Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Short-Term Solvency
Long-Term Solvency
77/100
Solvency
Score

3SBio Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
3SBio Inc

Wall Street analysts forecast 3SBio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 3SBio Inc is 7.7 HKD with a low forecast of 6.26 HKD and a high forecast of 10.08 HKD.

Lowest
Price Target
6.26 HKD
3% Upside
Average
Price Target
7.7 HKD
26% Upside
Highest
Price Target
10.08 HKD
65% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
3SBio Inc

1M 1M
+2%
6M 6M
-4%
1Y 1Y
-21%
3Y 3Y
-16%
5Y 5Y
-57%
10Y 10Y
-32%
Annual Price Range
6.1
52w Low
4.94
52w High
8.07
Price Metrics
Average Annual Return -9.71%
Standard Deviation of Annual Returns 26.01%
Max Drawdown -68%
Shares Statistics
Market Capitalization 14.6B HKD
Shares Outstanding 2 543 601 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

3SBio Inc Logo
3SBio Inc

Country

China

Industry

Biotechnology

Market Cap

14.6B HKD

Dividend Yield

4.1%

Description

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2015-06-11. The Company’s main products include recombinant human thrombopoietin (rhTPO) products, tumor necrosis factor (TNF)αinhibitor products and recombinant human erythropoietin (rhEPO) products. The products are sold under the name of TPIAO, Yisaipu, EPIAO and SEPO. The firm distributes its products within the domestic market and to overseas markets, including Sri Lanka, Dominican Republic and Thailand. The Company’s subsidiaries include Collected Mind Limited, Hongkong Sansheng Medical Limited and Shenyang Sunshine Pharmaceutical Co., Ltd.. Through its subsidiaries, the Company is engaged in project management and consultation.

Contact

LIAONING
Shenyang
No. 3, A1, Road 10, Shenyang Economy and Technology Development Zone
http://www.3sbio.com

IPO

2015-06-11

Employees

5 232

Officers

Co-Founder, Executive Chairman, CEO & President
Dr. Jing Lou M.D., Ph.D.
Senior VP & Executive Director
Dr. Dongmei Su
Chief Financial Officer
Mr. Xiang He
Company Secretary
Ms. Siu Kuen Lai FCIS, FCS
Executive of IR
Zhao Xinyi

See Also

Discover More
What is the Intrinsic Value of one 3SBio Inc stock?

The intrinsic value of one 3SBio Inc stock under the Base Case scenario is 8.83 HKD.

Is 3SBio Inc stock undervalued or overvalued?

Compared to the current market price of 6.1 HKD, 3SBio Inc is Undervalued by 31%.